Global Asthma and COPD Drug Market Insights and Forecast to 2026

1 Study Coverage

• 1.1 Asthma and COPD Drug Product Introduction
• 1.2 Key Market Segments in This Study
• 1.3 Key Manufacturers Covered: Ranking of Global Top Asthma and COPD Drug Manufacturers by Revenue in 2019
• 1.4 Market by Type
  • 1.4.1 Global Asthma and COPD Drug Market Size Growth Rate by Type
  • 1.4.2 Bronchodilators
  • 1.4.3 Anti-inflammatory Drugs
  • 1.4.4 Monoclonal Antibodies
  • 1.4.5 Combination Drugs
• 1.5 Market by Application
  • 1.5.1 Global Asthma and COPD Drug Market Size Growth Rate by Application
  • 1.5.2 Asthma
  • 1.5.3 COPD
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Asthma and COPD Drug Market Size, Estimates and Forecasts
  • 2.1.1 Global Asthma and COPD Drug Revenue Estimates and Forecasts 2015-2026
  • 2.1.2 Global Asthma and COPD Drug Production Capacity Estimates and Forecasts 2015-2026
  • 2.1.3 Global Asthma and COPD Drug Production Estimates and Forecasts 2015-2026
• 2.2 Global Asthma and COPD Drug, Market Size by Producing Regions: 2015 VS 2020 VS 2026
• 2.3 Analysis of Competitive Landscape
  • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 2.3.2 Global Asthma and COPD Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.3.3 Global Asthma and COPD Drug Manufacturers Geographical Distribution
• 2.4 Key Trends for Asthma and COPD Drug Markets & Products
• 2.5 Primary Interviews with Key Asthma and COPD Drug Players (Opinion Leaders)

3 Market Size by Manufacturers

• 3.1 Global Top Asthma and COPD Drug Manufacturers by Production Capacity
  • 3.1.1 Global Top Asthma and COPD Drug Manufacturers by Production Capacity (2015-2020)
  • 3.1.2 Global Top Asthma and COPD Drug Manufacturers by Production (2015-2020)
  • 3.1.3 Global Top Asthma and COPD Drug Manufacturers Market Share by Production
• 3.2 Global Top Asthma and COPD Drug Manufacturers by Revenue
  • 3.2.1 Global Top Asthma and COPD Drug Manufacturers by Revenue (2015-2020)
  • 3.2.2 Global Top Asthma and COPD Drug Manufacturers Market Share by Revenue (2015-2020)
  • 3.2.3 Global Top 10 and Top 5 Companies by Asthma and COPD Drug Revenue in 2019
• 3.3 Global Asthma and COPD Drug Price by Manufacturers
• 3.4 Mergers & Acquisitions, Expansion Plans

4 Asthma and COPD Drug Production by Regions

• 4.1 Global Asthma and COPD Drug Historic Market Facts & Figures by Regions
  • 4.1.1 Global Top Asthma and COPD Drug Regions by Production (2015-2020)
  • 4.1.2 Global Top Asthma and COPD Drug Regions by Revenue (2015-2020)
• 4.2 North America
  • 4.2.1 North America Asthma and COPD Drug Production (2015-2020)
  • 4.2.2 North America Asthma and COPD Drug Revenue (2015-2020)
  • 4.2.3 Key Players in North America
  • 4.2.4 North America Asthma and COPD Drug Import & Export (2015-2020)
• 4.3 Europe
  • 4.3.1 Europe Asthma and COPD Drug Production (2015-2020)
  • 4.3.2 Europe Asthma and COPD Drug Revenue (2015-2020)
  • 4.3.3 Key Players in Europe
  • 4.3.4 Europe Asthma and COPD Drug Import & Export (2015-2020)
• 4.4 China
  • 4.4.1 China Asthma and COPD Drug Production (2015-2020)
  • 4.4.2 China Asthma and COPD Drug Revenue (2015-2020)
  • 4.4.3 Key Players in China
  • 4.4.4 China Asthma and COPD Drug Import & Export (2015-2020)
• 4.5 Japan
  • 4.5.1 Japan Asthma and COPD Drug Production (2015-2020)
  • 4.5.2 Japan Asthma and COPD Drug Revenue (2015-2020)
  • 4.5.3 Key Players in Japan
  • 4.5.4 Japan Asthma and COPD Drug Import & Export (2015-2020)

5 Asthma and COPD Drug Consumption by Region

• 5.1 Global Top Asthma and COPD Drug Regions by Consumption
  • 5.1.1 Global Top Asthma and COPD Drug Regions by Consumption (2015-2020)
  • 5.1.2 Global Top Asthma and COPD Drug Regions Market Share by Consumption (2015-2020)
• 5.2 North America
  • 5.2.1 North America Asthma and COPD Drug Consumption by Application
  • 5.2.2 North America Asthma and COPD Drug Consumption by Countries
  • 5.2.3 U.S.
  • 5.2.4 Canada
• 5.3 Europe
  • 5.3.1 Europe Asthma and COPD Drug Consumption by Application
  • 5.3.2 Europe Asthma and COPD Drug Consumption by Countries
  • 5.3.3 Germany
  • 5.3.4 France
  • 5.3.5 U.K.
  • 5.3.6 Italy
  • 5.3.7 Russia
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Asthma and COPD Drug Consumption by Application
  • 5.4.2 Asia Pacific Asthma and COPD Drug Consumption by Regions
  • 5.4.3 China
  • 5.4.4 Japan
  • 5.4.5 South Korea
  • 5.4.6 India
  • 5.4.7 Australia
  • 5.4.8 Taiwan
  • 5.4.9 Indonesia
  • 5.4.10 Thailand
  • 5.4.11 Malaysia
  • 5.4.12 Philippines
  • 5.4.13 Vietnam
• 5.5 Central & South America
  • 5.5.1 Central & South America Asthma and COPD Drug Consumption by Application
  • 5.5.2 Central & South America Asthma and COPD Drug Consumption by Country
  • 5.5.3 Mexico
  • 5.5.3 Brazil
  • 5.5.3 Argentina
• 5.6 Middle East and Africa
  • 5.6.1 Middle East and Africa Asthma and COPD Drug Consumption by Application
  • 5.6.2 Middle East and Africa Asthma and COPD Drug Consumption by Countries
  • 5.6.3 Turkey
  • 5.6.4 Saudi Arabia
  • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

• 6.1 Global Asthma and COPD Drug Market Size by Type (2015-2020)
  • 6.1.1 Global Asthma and COPD Drug Production by Type (2015-2020)
  • 6.1.2 Global Asthma and COPD Drug Revenue by Type (2015-2020)
  • 6.1.3 Asthma and COPD Drug Price by Type (2015-2020)
• 6.2 Global Asthma and COPD Drug Market Forecast by Type (2021-2026)
  • 6.2.1 Global Asthma and COPD Drug Production Forecast by Type (2021-2026)
  • 6.2.2 Global Asthma and COPD Drug Revenue Forecast by Type (2021-2026)
  • 6.2.3 Global Asthma and COPD Drug Price Forecast by Type (2021-2026)
• 6.3 Global Asthma and COPD Drug Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

• 7.2.1 Global Asthma and COPD Drug Consumption Historic Breakdown by Application (2015-2020)
• 7.2.2 Global Asthma and COPD Drug Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

• 8.1 Boehringer Ingelheim
  • 8.1.1 Boehringer Ingelheim Corporation Information
  • 8.1.2 Boehringer Ingelheim Overview
  • 8.1.3 Boehringer Ingelheim Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.1.4 Boehringer Ingelheim Product Description
  • 8.1.5 Boehringer Ingelheim Related Developments
• 8.2 GlaxoSmithKline
  • 8.2.1 GlaxoSmithKline Corporation Information
  • 8.2.2 GlaxoSmithKline Overview
  • 8.2.3 GlaxoSmithKline Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.2.4 GlaxoSmithKline Product Description
  • 8.2.5 GlaxoSmithKline Related Developments
• 8.3 Merck and Co
  • 8.3.1 Merck and Co Corporation Information
  • 8.3.2 Merck and Co Overview
  • 8.3.3 Merck and Co Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.3.4 Merck and Co Product Description
  • 8.3.5 Merck and Co Related Developments
• 8.4 Novartis AG
  • 8.4.1 Novartis AG Corporation Information
  • 8.4.2 Novartis AG Overview
  • 8.4.3 Novartis AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.4.4 Novartis AG Product Description
  • 8.4.5 Novartis AG Related Developments
• 8.5 AstraZeneca
  • 8.5.1 AstraZeneca Corporation Information
  • 8.5.2 AstraZeneca Overview
  • 8.5.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.5.4 AstraZeneca Product Description
  • 8.5.5 AstraZeneca Related Developments
• 8.6 F. Hoffmann-La Roche
  • 8.6.1 F. Hoffmann-La Roche Corporation Information
  • 8.6.2 F. Hoffmann-La Roche Overview
  • 8.6.3 F. Hoffmann-La Roche Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
  • 8.6.4 F. Hoffmann-La Roche Product Description
  • 8.6.5 F. Hoffmann-La Roche Related Developments

9 Asthma and COPD Drug Production Forecast by Regions

• 9.1 Global Top Asthma and COPD Drug Regions Forecast by Revenue (2021-2026)
• 9.2 Global Top Asthma and COPD Drug Regions Forecast by Production (2021-2026)
• 9.3 Key Asthma and COPD Drug Production Regions Forecast
  • 9.3.1 North America
  • 9.3.2 Europe
  • 9.3.3 China
  • 9.3.4 Japan

10 Asthma and COPD Drug Consumption Forecast by Region

• 10.1 Global Asthma and COPD Drug Consumption Forecast by Region (2021-2026)
• 10.2 North America Asthma and COPD Drug Consumption Forecast by Region (2021-2026)
• 10.3 Europe Asthma and COPD Drug Consumption Forecast by Region (2021-2026)
• 10.4 Asia Pacific Asthma and COPD Drug Consumption Forecast by Region (2021-2026)
• 10.5 Latin America Asthma and COPD Drug Consumption Forecast by Region (2021-2026)
• 10.6 Middle East and Africa Asthma and COPD Drug Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Asthma and COPD Drug Sales Channels
  • 11.2.2 Asthma and COPD Drug Distributors
• 11.3 Asthma and COPD Drug Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

• 12.1 Asthma and COPD Drug Industry
• 12.2 Market Trends
• 12.3 Market Opportunities and Drivers
• 12.4 Market Challenges
• 12.5 Asthma and COPD Drug Market Risks/Restraints
• 12.6 Porter's Five Forces Analysis

13 Key Finding in The Global Asthma and COPD Drug Study

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
  • 14.1.2 Data Source
• 14.2 Author Details